📋 Material Events 1086

Extraordinary reports (臨時報告書) — AI-classified EDINET Doc 180 filings. ~1yr coverage, updated daily.

Date Company Category Summary Amount
2026-02-04
4676
💰 Buyback
The company entered into a contract on February 3, 2026 with major shareholders (Reno Co., Ltd., S-Grant Corporation, City Index First Co., Ltd., Ayumi Nomura, and Yoshiaki Murakami) to acquire approximately 235 billion yen worth of the company's issued ordinary shares via ToSTNeT-3 trading. The agreement includes restrictions on voting rights, share transfer prohibitions, and stock ownership caps to support the company's reform action plan and accelerate ROE targets.
¥235.0bn
2026-02-04
4972
👤 Shareholder Rights
Axium Capital Pte. Ltd. increased its stake in the company from 9.99% to 10.19% of voting rights, crossing the 10% threshold for major shareholders. The stake increase of 325 voting rights occurred on January 27, 2026, and is reported based on a large shareholding report filed by the shareholder on February 3, 2026.
2026-02-04
3902
🤝 Acquisition
Nippon Life Insurance Company (日本生命保険相互会社) has successfully completed a tender offer for the company's ordinary shares and subscription rights, acquiring 20,082,496 shares during the offer period from December 16, 2025 to February 3, 2026. Upon settlement on February 9, 2026, Nippon Life will become the parent company and largest shareholder with 52.34% voting rights ownership.
2026-02-04
7455
🤝 Acquisition
Renetto Corporation (公開買付者) launched a public tender offer to acquire all outstanding shares of the company at 581 yen per share, aiming to take it private as a management buyout. Following the successful tender offer where Renetto acquired 42,628,323 shares (73.20% ownership) as of January 6, 2026, the company will hold an extraordinary shareholder meeting on March 6, 2026 to approve a stock consolidation (株式併合) to squeeze out remaining minority shareholders.
¥24.7bn
2026-02-04
9010
💰 Special Dividend
The company has decided to partially withdraw from its retirement benefit trust (退職給付信託) due to a significant surplus of plan assets relative to pension liabilities. The company expects to record approximately 600 million yen as extraordinary profit from the trust withdrawal in the fiscal year ending March 2026.
¥600M
2026-02-04
8011
🏗️ Asset Sale
The company decided to sell a portion of its investment securities holdings as part of asset optimization efforts. The sale is planned for February 2026 and is expected to generate investment securities gains of approximately 3.9-4.1 billion yen to be recorded as extraordinary profit.
¥4.0bn
2026-02-04
7769
🤝 Merger
The company will conduct an absorption merger in June 2026, with RHYTHM HONG KONG CO., LTD. (consolidated subsidiary) as the surviving company and RHYTHM INDUSTRIAL (H.K.) LTD. (specified subsidiary) as the disappearing company. As a result, RHYTHM INDUSTRIAL (H.K.) LTD. will cease to be a specified subsidiary of the company.
2026-02-04
6331
🏗️ Asset Sale
The company executed the sale of two parcels of rental real estate (parking lots) totaling 605.86 m² located in Kawasaki, Kanagawa on January 27, 2026, as part of its medium-term management plan to compress non-business assets. The transaction is expected to generate a gain of approximately 1,381 million yen, which will be recorded as extraordinary income in the fiscal year ending March 2026.
¥1.4bn
2026-02-04
5461
👤 CEO
Shigematsu Kumio was promoted from Chairman (取締役会長) to Representative Director and Chairman (代表取締役会長) by board resolution on February 3, 2026. This represents an additional appointment of representative director authority, as he transitions from his previous role as Representative Director President (代表取締役社長) in June 2025.
2026-02-04
6157
👤 Shareholder Rights
Solupti Corporation (株式会社ソルプティ) has become a major shareholder of the company, with its voting rights stake increasing from 9.76% to 10.00% as of February 3, 2026. The change in percentage is due to adjustments in total shareholder voting rights resulting from treasury stock transactions, including restricted stock awards and share acquisitions.
2026-02-04
4838
👤 CEO
The company announced a change in representative director status at a board meeting held on January 30, 2026. Tomohiro Okubo will transition from Representative Director and Co-President to Director and Vice President, effective April 1, 2026.
2026-02-04
4809
💰 Equity
Paraka Corporation's Board of Directors resolved on February 3, 2026 to issue 500 stock warrants (新株予約権) as employee stock options on February 24, 2026. The warrants will be granted to company employees at no cost, with each warrant exercisable for 100 common shares, totaling 50,000 shares. The exercise price will be determined based on the Black-Scholes model on the allocation date, with an exercise period from February 25, 2028 to February 3, 2034.
2026-02-03
2871
🏗️ Establishment
Nichirei Global Foods, LLC, a subsidiary of InnovAsian Cuisine Enterprises Inc. (which is owned by Nichirei Foods Co., Ltd.), will undergo a capital increase from $1,000 to $105,701,000. This capital increase will cause the subsidiary's capital to exceed 10% of the parent company's capital, thereby qualifying it as a specified subsidiary (特定子会社) requiring disclosure under the Financial Instruments and Exchange Act.
2026-02-03
5444
🏗️ Asset Sale
The company's Board of Directors resolved on February 2, 2026 to sell a portion of its held investment securities to improve asset efficiency. The company expects to record approximately 13 billion yen in gains from the sale of investment securities as extraordinary income in the fiscal year ending March 2026.
¥13.0bn
2026-02-03
5246
👤 CEO
Yasuhiro Hisada, who has served as Representative Director and Chairman, will step down from his positions effective February 26, 2026, upon the conclusion of the company's 12th regular shareholders' meeting. The board of directors resolved on this management change at their February 3, 2026 meeting.
2026-02-03
7013
👤 Shareholder Rights
Capital Research and Management Company has crossed the threshold to become a major shareholder of the company. The company's voting rights increased from 8.97% to 10.40% of total shareholder voting rights as of January 26, 2026, following a 7-for-1 stock split executed on October 1, 2025.
2026-02-03
6503
🏗️ Business Suspension
The company implemented a 'Next Stage Support Program' special measure offering early retirement incentives to employees aged 53+ with 3+ years of service. A total of 2,378 employees applied during the recruitment period (December 15, 2025 - January 9, 2026), with retirement effective March 15, 2026. The company will record approximately 65 billion yen in special losses in the fiscal year ending March 2026.
¥65.0bn
2026-02-03
4967
💥 Impairment
Kobayashi Pharmaceutical has recorded impairment losses totaling 14,645 million yen on its consolidated financial statements for the fiscal year ending December 2025 due to reduced profitability forecasts for two pharmaceutical manufacturing facilities under construction: the Sendai New Factory in Miyagi Prefecture and the Thailand Factory operated by KOBAYASHI Pharmaceutical Manufacturing (Thailand) Co., Ltd. Both projects have experienced delays in quality management systems implementation and production timelines, requiring extended validation periods and increased costs beyond initial projections.
¥14.6bn
2026-02-03
4543
🤝 Merger
Kalila Medical, Inc., a wholly-owned subsidiary of the reporting company, was absorbed and merged into Terumo Medical Corp. (another subsidiary) effective January 31, 2026. As a result, Kalila Medical, Inc. ceased to exist as a separate legal entity and is no longer classified as a specific subsidiary of the reporting company.
2026-02-03
🏗️ Asset Sale
The company is selling a portion of its shares in Kanden Engineering Co., Ltd. (株式会社関電工), generating a gain on sale. The company expects to record 28.6 billion yen in special gains from securities sale proceeds in the individual financial statements for the fiscal year ending March 2026.
¥28.6bn
2026-02-03
6678
👤 Shareholder Rights
A change in major shareholder occurred following the completion of inheritance procedures on January 27, 2026. Masatomo Jitsuyoshi became the new major shareholder, increasing his voting rights from 2,253 shares (3.25%) to 11,416 shares (16.46%), succeeding the deceased major shareholder Shigeyuki Jitsuyoshi.
2026-02-03
9759
👤 CEO
The company announced the appointment of Hidetaka Kiwada as a new Representative Director (代表取締役) effective April 1, 2026, following a Board of Directors resolution on January 30, 2026. Kiwada will transition from his current position as Senior Executive Officer (専務執行役員) while maintaining his existing directorship, bringing extensive experience in advanced technology and innovation strategy.
2026-02-03
4005
💥 Impairment
The company recognized an impairment loss of 13,361 million yen on its equity investment in Rabigh Refining and Petrochemical Company (an equity method affiliate) due to significant decline in fair value of Class A ordinary shares. The impairment loss is recorded as a special loss in the individual financial statements for the third quarter of fiscal year 2026, but will be eliminated in consolidated financial statements with no impact on consolidated results.
¥13.4bn
2026-02-03
4438
💥 Impairment
The company recognized an impairment loss of 94 million yen on fixed assets (software, etc.) for the fiscal year ended December 2025. The impairment was recorded based on a careful review of future recoverability in light of recent business performance trends, in accordance with accounting standards for asset impairment.
¥94M
2026-02-03
💥 Impairment
The company's subsidiary Katsumi Global, LLC is significantly impacted by the Chapter 11 bankruptcy filing of its factoring client First Brands Group, LLC (FBG) in February 2026. FBG is under investigation for suspected fraud including inflated invoices, fictitious receivables, and multiple assignments of the same debt, with founders facing criminal charges. The company is recording an additional allowance for doubtful accounts of 150,458 million yen in Q3 FY2026.
¥150.5bn
2026-02-03 💰 Equity
The company is conducting a third-party allocation capital increase (新株式発行) on February 27, 2026, whereby Riken J Technologies LLC will acquire 62,500 voting rights (41.74% of total), becoming the new lead major shareholder. Consequently, individual shareholder Kazushi Watanabe will cease to be a major shareholder as his ownership percentage drops below 10% (from 13.65% to 7.95%).
2026-02-03
4188
🏗️ Business Suspension
Mitsubishi Chemical Group announced on February 2, 2026, that its subsidiary Mitsubishi Chemical Corporation will exit the coke and carbon material business (needle coke and pitch coke) produced at its Kagawa facility. The company expects to record approximately 85 billion yen in total non-recurring losses, including impairment losses of approximately 19 billion yen in Q3 FY2026 and approximately 66 billion yen in removal and employee support costs in Q4 FY2026.
¥8.5bn
2026-02-03
💥 Earnings Revision
One Fidelity Blue Chip Growth Stock Fund (bi-monthly settlement type with expected dividend presentation) filed its 12th calculation period report for the period from November 21, 2025 to January 20, 2026. The fund distributed 400 yen per 10,000 units and reported a period-over-period rate of change of 6.08%, with total net assets of approximately 47.6 billion yen and a unit price of 13,071 yen per 10,000 units as of the end of the period.
¥47.6bn
2026-02-03
💥 Earnings Revision
Shinko 7-Asset Balanced Fund filed an extraordinary report disclosing trust asset calculations and performance metrics for three consecutive calculation periods (227th-229th) ending January 20, 2026. The report details dividend distributions of 20 yen per 10,000 units, period-end net asset values ranging from approximately 4.8 to 4.9 billion yen, and period performance rates between 1.30% and 2.46%.
¥4.9bn
2026-02-02
2282
👤 CEO
The company announces a change in representative directors effective April 1, 2026. Maeda Fumio will assume the position of Representative Director and President, transitioning from his role as Senior Managing Executive Officer and Vice President. Ikawa Nobuhisa, the current Representative Director and President, will step down from the representative director position to become Chairman of the Board of Directors.
2026-02-02
6481
🤝 Divestiture
The company decided on February 2, 2026 to divest all issued shares and outstanding loans related to five subsidiary companies (TRA Holdings, THK Rhythm Automotive Canada, Czech, Germany, and Michigan operations) to AP87, a special purpose company indirectly backed by a fund managed by Advantage Partners. The divestiture also includes six indirect subsidiaries under TRA Holdings and is expected to close on June 1, 2026, with a material impact on the company's financial position and operating results.
2026-02-02
6971
👤 CEO
The company announced a management transition effective April 1, 2026, in which Shiro Sakurajima will become the new Representative Director and President (CEO), while Hideo Ina will become Representative Director Vice Chairman. The incumbent CEO Hideo Tanamoto will step down from the Representative Director position and retire as a director at the June 2026 shareholder meeting.
2026-02-02
7241
🏗️ Liquidation
The company's board of directors resolved on February 2, 2026 to initiate liquidation proceedings for its consolidated subsidiary Tianjin Shuangxie Machinery Industrial Co., Ltd. (天津双協機械工業有限公司). To address the subsidiary's debt-to-equity deficit, the parent company will convert it to a wholly-owned subsidiary and inject additional capital before commencing liquidation. The company expects to record approximately 3.0 billion yen in special losses related to the subsidiary's liquidation in the fiscal year ending March 2026, though this will be eliminated in consolidated financial statements.
¥3.0bn
2026-02-02
2760
👤 CEO
The company's board of directors approved changes to representative director positions effective April 1, 2026. Tokushige Atsuyuki transitions from Representative Director President/CEO to Representative Director Chairman/CEO, while Miyamoto Takayoshi is promoted from Director to Representative Director President/CEO. Hasegawa Masami transitions from Representative Director Executive Vice President to Director.
2026-02-02
9258
🤝 Acquisition
The company's subsidiary CS-R will acquire all shares of Gottsuu Co., Ltd. to make it a subsidiary. The acquisition is planned for mid-February 2026, with a total cost of approximately 153 million yen including stock acquisition price (120 million yen) and advisory fees (33 million yen).
¥153M
2026-02-02
7635
🤝 Acquisition
The company's board of directors resolved on February 2, 2026 to convene an extraordinary shareholders meeting on March 3, 2026 to approve a stock consolidation in connection with an MBO transaction. UMK Corporation launched a tender offer for all outstanding shares (excluding treasury stock and non-tendering shareholders' shares totaling 1,999,000 shares), acquiring 2,930,441 shares (54.62%) at 1,710 yen per share through December 25, 2025.
¥5.0bn
2026-02-02
7283
💰 Equity
Assan Industries resolved to dispose of treasury shares (320,800 shares) to the Assan Industries Employee Stock Ownership Association through a restricted stock incentive program for employees. The shares will be issued at 2,195 yen per share for a total amount of approximately 704.16 million yen, with a restriction period from July 1, 2026 to June 30, 2029.
¥704M
2026-02-02
5711
👤 Shareholder Rights
Silchester International Investors LLP, a major shareholder, has reduced its stake below the 10% threshold. The shareholding decreased from 133,525 voting rights (10.28% of total) as of January 13, 2026, to 117,466 voting rights (9.04% of total) as of January 28, 2026, resulting in the loss of major shareholder status.
2026-02-02
👤 CEO
The company's Board of Directors resolved on January 29, 2026 to change the Representative Director (CEO). Hirofumi Kuwata, currently Senior Vice President and Chief Operating Officer, will be promoted to Representative Director and President effective April 1, 2026. Takashi Maruyama, the current Representative Director and President, will transition to the role of Chairman of the Board.
2026-02-02
3622
💥 Earnings Revision
The company is recognizing advisory fees of 86 million yen as a special loss in FY2026 March period related to financial strategy consultations aimed at mid-to-long-term corporate value enhancement. This event materially impacts the company's financial condition, operating results, and cash flow situation.
¥86M
2026-01-30
9513
👤 CEO
J-Power (Electric Power Development Co., Ltd.) announced a change in representative director effective April 1, 2026. Hideaki Kato will succeed Hitoshi Sugano as Representative Director and President. Sugano will transition to President Executive Officer role while Kato will assume the title of President and Representative Director.
2026-01-30
8233
💰 Buyback
The company announced the repurchase and planned retirement of its 2028 maturity Euro yen-denominated convertible bonds with warrant rights. The total principal amount of bonds to be repurchased is 5,999.0 billion yen, with the repurchase to be completed on February 26, 2026, resulting in a special loss to be recorded in the February 2026 financial statements.
¥99.1bn
2026-01-30
6777
🤝 Divestiture
Santec Holdings approved an absorption-type spin-off effective April 1, 2026, transferring its asset management division to its wholly-owned subsidiary Aqumen Capital Co., Ltd. The spin-off is designed to consolidate asset management operations within the group, enhance asset efficiency, and strengthen the financial foundation for future business and growth investments. No consideration will be exchanged as the transaction involves only a parent and its wholly-owned subsidiary.
2026-01-30
2796
🤝 Acquisition
The company's board of directors resolved on January 30, 2026 to acquire all shares of Sanko Medical Co., Ltd., a pharmaceutical wholesaler, and make it a subsidiary. This acquisition is part of the company's mid-term management plan 'Make a Leap 2027' aimed at strengthening the group's pharmaceutical distribution system and expanding region-focused medical services in the Kanto region.
¥1600
2026-01-30
1964
👤 CEO
The company's Board of Directors resolved on January 30, 2026 to transition the representative director roles effective April 1, 2026. Akira Ozaki will move from Representative Director and President to Representative Director and Chairman, while Mamoru Sakata will be promoted from Director and Managing Executive Officer to Representative Director and President Executive Officer.
2026-01-30
👤 CEO
The company announced a change in representative director (CEO equivalent) effective April 1, 2026. Yutaka Kaiyama will assume the position of Representative Director and President, replacing Noriyuki Hara who will transition to Chairman. The parent company MS&AD Insurance Group Holdings approved the succession on January 30, 2026.
2026-01-30
2978
💰 Debt
Tsukuruba Box Co., Ltd., a subsidiary of Tsukuruba Co., Ltd., entered into an overdraft facility agreement with a major Japanese bank on January 30, 2026, for a maximum principal amount of ¥1,000 million. The facility is secured by a first-priority mortgage on the target real estate property and a joint guarantee from the parent company Tsukuruba Co., Ltd., with financial covenants including equity ratio maintenance, profit requirements, and inventory turnover ratio restrictions.
¥1.0bn
2026-01-30
7074
👤 Board
The company has resolved to replace its accounting auditor firm effective February 26, 2026, at the 18th Annual Shareholders Meeting. Yamato Audit Corporation, whose term ends on that date, will be replaced by San-Yu Audit Corporation after comparative evaluation of audit implementation体制, audit policies, quality management, and audit fees.
2026-01-30
1949
🤝 Acquisition
Sumitomo Electric Industries' subsidiary Sumitomo Densetsu has decided to issue A-class preferred shares to Daiwa House Industry for approximately 123 billion yen through third-party allotment. The proceeds will fund the acquisition of all ordinary shares held by Sumitomo Electric Industries, enabling Daiwa House to achieve complete subsidiary status following its successful public tender offer in December 2025.
¥123.0bn
2026-01-30
3465
💰 Debt
The company entered into a loan agreement with urban and system financial institutions on January 30, 2026, for 8.5 billion yen with repayment due March 31, 2027. The loan is secured by a blanket mortgage on land and includes financial covenants requiring maintenance of equity at 75% of baseline levels and preventing two consecutive periods of operating losses.
¥8.5bn
Showing 701–750 of 1086
← Prev 15 / 22 Next →